First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

H Andrikovics, S Nahajevszky, A Szilvási… - Hematological …, 2007 - Wiley Online Library
During the formation of the Philadelphia (Ph) chromosome, in the majority of chronic
myelogenous leukemia (CML) patients, the chromosome 22 breakpoint is located in the …
被引用次数：40 相关文章

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.

H Andrikovics, S Nahajevszky, A Szilvási… - Hematological …, 2007 - europepmc.org
During the formation of the Philadelphia (Ph) chromosome, in the majority of chronic
myelogenous leukemia (CML) patients, the chromosome 22 breakpoint is located in the …

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

H Andrikovics, S Nahajevszky, A Szilvási, A Bors… - Hematological …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> During the formation of the Philadelphia (Ph)
chromosome, in the majority of chronic myelogenous leukemia (CML) patients, the …

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts

H Andrikovics, S Nahajevszky… - Hematological …, 2007 - pubmed.ncbi.nlm.nih.gov
During the formation of the Philadelphia (Ph) chromosome, in the majority of chronic
myelogenous leukemia (CML) patients, the chromosome 22 breakpoint is located in the …
[PDF] academia.edu

[PDF][PDF] First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

H Andrikovics, S Nahajevszky, A Szilvási, A Bors… - Hematol …, 2007 - academia.edu
During the formation of the Philadelphia (Ph) chromosome, in the majority of chronic
myelogenous leukemia (CML) patients, the chromosome 22 breakpoint is located in the …